AVR anteris technologies global corp.

0.17%

$6.03

Pretty sure they applied to run ViV in the pivotal trial and it...

First 7 Last

Share
Profile

Follow
lexcorp

8,061 Posts.

530

21/11/24

07:38

Post #: 76703907
Share

Originally posted by synaphai ↑

As Eire and I have discussed in the past, the wildcard is a Humanitarian Device Exemption being granted for ViV by the FDA at some point. That would allow up to 8000 DurAVR's to be sold in the US each year for a profit. Being a blanket coverage, it's likely easier to manage than similar programs in other countries like with Canada's Special Access Program where doctors have to submit a request to Health Canada each time they want to use an unapproved device.

The problem with the HUD is it requires there be no comparable approved devices currently available, and there are currently approved options for the procedure. The question then may come down to how strict is the interpretation of what is comparable. So there may be a chance although I would not put the odds in our favor. Another question is how much evidence will Anteris need to prove that the DurAVR is superior and thus not comparable to currently approved options. It may be worthwhile to start the FDA approved ViV trial as soon as possible because it will be smaller and could be completed sooner than the large pivotal trial if enrolling the 1000 or more patients in the pivotal drags on and on.

So there seems to me to be a potential dilemma: Do you try to run the ViV trial concurrently from the start knowing that it will siphon money and resources from the pivotal, which could delay the pivotal, for the chance to petition the FDA as to whether the DurAVR is comparable to existing ViV options? Or do you wait because the odds may be not good that a HUD would be granted? That's the kind of decision Wayne gets paid the big bucks to make.

Expand

Pretty sure they applied to run ViV in the pivotal trial and it was to go ahead

AVR Price at posting: $9.22 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

PIQ

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.03		Change 0.010(0.17%)		Mkt cap ! $93.45M

Open	High	Low	Value	Volume
$6.00	$6.16	$5.80	$52.24K	8.792K

Buyers (Bids)

No.	Vol.	Price($)
1	857	$5.83

Sellers (Offers)

Price($)	Vol.	No.
$6.45	1000	1

View Market Depth

No.	Vol.	Price($)
1	857	5.830
1	200	5.800
1	900	5.780
1	450	5.750
1	1000	5.610

Price($)	Vol.	No.
6.450	1000	1
6.550	1092	1
6.650	100	1
6.910	1000	1
7.010	1000	1

Last trade - 15.36pm 20/06/2025 (20 minute delay)

AVR (ASX) Chart

Pretty sure they applied to run ViV in the pivotal trial and it...

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Pretty sure they applied to run ViV in the pivotal trial and it...

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News